John C. Martin, Ph.D.
Chairman of the Board and Chief Executive Officer
Gilead Sciences

John C. Martin, Ph.D., joined Gilead Sciences in 1990 and currently serves as chairman of the board of directors and CEO. Prior to joining Gilead, Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corp.

Martin has served as president of the International Society for Antiviral Research, chairman of the board of directors of BayBio and chairman of the California Healthcare Institute. He also served on the National Institute of Allergy & Infectious Diseases Council, on the board of directors of the Biotechnology Industry Organization (BIO), on the board of trustees of the University of Chicago and on the board of trustees of the Golden Gate University. Additionally, Martin served on the Centers for Disease Control/Health Resources and Services Administrations Advisory Committee on HIV and STD Prevention and Treatment and was a member of the Presidential Advisory Council on HIV/AIDS. He is currently a member of the board at Gen-Probe Inc. He has been a member of the board of directors of CHI since 2003 and previously served as chairman of the board from 2005 to 2006 and 2009.

Martin received his doctorate in organic chemistry from the University of Chicago and a master’s degree in marketing from Golden Gate University. He received the Isbell Award from the American Chemical Society and the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research. In 2008, he was inducted into the National Academy of Engineering.